跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Atorvastatin Calcium/Ezetimibe
首页
药物
Atorvastatin Calcium/Ezetimibe
Atorvastatin Calcium/Ezetimibe
未知生产厂商
订阅
生成 AI 研报
Share to Twitter
Share to Facebook
Share to LinkedIn
Share to Reddit
摘要
临床试验
审批记录
专利
每项发明一条,涵盖美国、欧洲、PCT 与中国的同族专利。
Dispersible tablets containing cholesterol absorption inhibitor and lipid regulating drug, and application thereof
CN 102451161 A
申请人: LIYAN WANG
优先权: 2010
CN
Composition capable of curing abnormal blood lipid
CN 103127115 A
申请人: BEIJING TIANHENG DRUG RES INST
优先权: 2011
CN
Composition containing ezetimibe and atorvastatin calcium and preparation method of composition
CN 104013617 A
申请人: AVENTIS PHARMA HAINAN CO LTD
优先权: 2014
CN
PHARMACEUTICAL BILAYER TABLET COMPOSITION OF ATORVASTATIN CALCIUM AND EZETIMIBE
EP 3360541 A1
申请人: SANOVEL ILAC SANAYI VE TICARET AS
优先权: 2017
EP
Preparation method of ezetimibe atorvastatin calcium tablets
CN 107875129 A
申请人: BEIJING JIALIN PHARMACEUTICAL CO LTD
优先权: 2017
CN
Preparation containing ezetimibe and atorvastatin calcium and preparation method thereof
CN 117243910 A
申请人: SHANDONG CHUANGXIN PHARMACEUTICAL RES AND DEVELOPMENT CO LTD
优先权: 2023
CN
Ezetimibe atorvastatin calcium tablet and preparation method thereof
CN 117815190 A
申请人: NANJING FANHAI PHARMACEUTICAL TECH CO LTD
优先权: 2023
CN
Ezetimibe and atorvastatin calcium compound preparation and preparation method thereof
CN 120837492 A
申请人: NANJING KANG CHUAN JI PHARMATECH CO LTD
优先权: 2025
CN
Preparation method of ezetimibe atorvastatin calcium tablet
CN 120899653 A
申请人: JIANGSU YABANG AIPUSEN PHARMACEUTICAL CO LTD
优先权: 2025
CN
药物
反馈